Jerome O Cantor Selected Research

Pulmonary Emphysema

1/2021	A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy.
1/2016	Biomarkers in Alpha-1 Antitrypsin Deficiency Chronic Obstructive Pulmonary Disease.
11/2005	Dichotomous effect of aerosolized hyaluronan in a hamster model of endotoxin-induced lung injury.
5/2005	Aerosolized hyaluronan limits airspace enlargement in a mouse model of cigarette smoke-induced pulmonary emphysema.
1/2004	Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema?
2/2002	The effect of lysozyme on elastase-mediated injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jerome O Cantor Research Topics

Disease

7	Pneumonia (Pneumonitis) 11/2009 - 11/2005
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2007
6	Pulmonary Emphysema 01/2021 - 02/2002
5	Emphysema 01/2018 - 02/2002
3	Lung Diseases (Lung Disease) 03/2008 - 01/2006
3	Lung Injury 07/2007 - 11/2005
2	Acute Lung Injury 11/2009 - 03/2008
2	Inflammation (Inflammations) 11/2009 - 01/2007
1	Disease Progression 01/2018
1	Necrosis 11/2009
1	Neoplasms (Cancer) 11/2009
1	Hyperoxia 01/2006

Drug/Important Bio-Agent (IBA)

6	ElastinIBA 01/2021 - 01/2004
6	SmokeIBA 12/2008 - 01/2004
5	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 01/2004
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2011
4	Pancreatic Elastase (Elastase)IBA 01/2018 - 02/2002
3	IsodesmosineIBA 01/2021 - 01/2004
3	DesmosineIBA 01/2021 - 01/2004
3	LipopolysaccharidesIBA 11/2009 - 01/2008
3	Endothelin-1 (Endothelin 1)IBA 12/2008 - 01/2008
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2021 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
2	Amino Acids FDA Link 11/2009 - 01/2004
2	EndotoxinsIBA 01/2007 - 11/2005
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	AerosolsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2016
1	Fibrinogen (Factor I)FDA Link 01/2016
1	Glutathione PeroxidaseIBA 11/2009
1	Glutathione (Reduced Glutathione)IBA 11/2009
1	Superoxide DismutaseIBA 11/2009
1	Taurine FDA Link 11/2009
1	CatalaseIBA 11/2009
1	Caspase 3 (Caspase-3)IBA 11/2009
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 03/2008
1	Endothelin-Converting EnzymesIBA 03/2008
1	phosphoramidonIBA 03/2008
1	Amiodarone (Amiodarona)FDA LinkGeneric 07/2007
1	Polysaccharides (Glycans)IBA 01/2007
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2007
1	Oxidants (Oxidizing Agents)IBA 01/2006
1	Muramidase (Lysozyme)IBA 02/2002

Therapy/Procedure

2	Therapeutics 01/2018 - 09/2011